Drug prescribing pattern and clinical outcome in intensive care unit of a Dedicated COVID Hospital: A retrospective observational study

Teli Shaikh Emaran Shaikh Ismail; Chetan Suresh Bhangale; Harshal M Mahajan; Vijay B Gaikwad

doi:10.5455/njppp.2022.12.09345202126092021

2024, Vol: 14, Issue: 4

14 / 4Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

Authorship Declaration

« Previous Article

Original Research

Online Publishing Date:
20 / 10 / 2021

Natl J Physiol Pharm Pharmacol. 2022; 12(4): 472-476

doi: 10.5455/njppp.2022.12.09345202126092021

Drug prescribing pattern and clinical outcome in intensive care unit of a Dedicated COVID Hospital: A retrospective observational study

Teli Shaikh Emaran Shaikh Ismail, Chetan Suresh Bhangale, Harshal M Mahajan, Vijay B Gaikwad.

Abstract
Background: Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. Various drug treatment protocols using drugs such as Vitamin C, hydroxychloroquine, Remdesivir, Tocilizumab, Favipiravir, Interferons, etc. were recommended by governments across globe.

Aim and Objectives: The present study aims to assess Drug Prescribing Pattern and Clinical Outcome in Intensive Care Unit (ICU) of a Dedicated COVID Hospital.

Materials and Methods: The present study was of retrospective, analytical type conducted at Government Medical College, Jalgaon which was a Dedicated COVID hospital. Medical records of 111 patients of Covid 19 who received treatment in ICU of Government Medical College, Jalgaon from August 2020 to December 2020 were included in the present study.

Results: Out of 111 patients with confirmed Covid19 infection, majority belonged to the age group of 5160 years (24.3%), followed by 4150 years (22.5%) and 6170 years (20.7%). On analyzing the primary drugs prescribed, heparin was most commonly prescribed drug (95.5%) followed by corticosteroid (94.6%), Tocilizumab (39%), Oseltamivir (37%), and Remdesivir (31%). Out of patients who were cured, the majority had received heparin followed by corticosteroid, Oseltamivir, Remdesivir, Oseltamivir, and Tocilizumab.

Conclusion: In the present study corticosteroid and heparin were the most commonly prescribed drugs. Clinical outcomes were better in patient who received remdesivir, steroid, and heparin. The present study is an attempt to fill the lacuna of dearth of data on prescribing pattern of various drugs used in the treatment of moderate to severe Covid19 disease.

Key words: Prescribing; Pattern; Outcome; Coronavirus Disease

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Teli Shaikh Emaran Shaikh Ismail Articles by Chetan Suresh Bhangale Articles by Harshal M Mahajan Articles by Vijay B Gaikwad
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Ismail TSES, Bhangale CS, Mahajan HM, Gaikwad VB. Drug prescribing pattern and clinical outcome in intensive care unit of a Dedicated COVID Hospital: A retrospective observational study. Natl J Physiol Pharm Pharmacol. 2022; 12(4): 472-476. doi:10.5455/njppp.2022.12.09345202126092021

Web Style

Ismail TSES, Bhangale CS, Mahajan HM, Gaikwad VB. Drug prescribing pattern and clinical outcome in intensive care unit of a Dedicated COVID Hospital: A retrospective observational study. https://www.njppp.com/?mno=126707 [Access: March 14, 2024]. doi:10.5455/njppp.2022.12.09345202126092021

AMA (American Medical Association) Style

Ismail TSES, Bhangale CS, Mahajan HM, Gaikwad VB. Drug prescribing pattern and clinical outcome in intensive care unit of a Dedicated COVID Hospital: A retrospective observational study. Natl J Physiol Pharm Pharmacol. 2022; 12(4): 472-476. doi:10.5455/njppp.2022.12.09345202126092021

Vancouver/ICMJE Style

Ismail TSES, Bhangale CS, Mahajan HM, Gaikwad VB. Drug prescribing pattern and clinical outcome in intensive care unit of a Dedicated COVID Hospital: A retrospective observational study. Natl J Physiol Pharm Pharmacol. (2022), [cited March 14, 2024]; 12(4): 472-476. doi:10.5455/njppp.2022.12.09345202126092021

Harvard Style

Ismail, T. S. E. S., Bhangale, . C. S., Mahajan, . H. M. & Gaikwad, . V. B. (2022) Drug prescribing pattern and clinical outcome in intensive care unit of a Dedicated COVID Hospital: A retrospective observational study. Natl J Physiol Pharm Pharmacol, 12 (4), 472-476. doi:10.5455/njppp.2022.12.09345202126092021

Turabian Style

Ismail, Teli Shaikh Emaran Shaikh, Chetan Suresh Bhangale, Harshal M Mahajan, and Vijay B Gaikwad. 2022. Drug prescribing pattern and clinical outcome in intensive care unit of a Dedicated COVID Hospital: A retrospective observational study. National Journal of Physiology, Pharmacy and Pharmacology, 12 (4), 472-476. doi:10.5455/njppp.2022.12.09345202126092021

Chicago Style

Ismail, Teli Shaikh Emaran Shaikh, Chetan Suresh Bhangale, Harshal M Mahajan, and Vijay B Gaikwad. "Drug prescribing pattern and clinical outcome in intensive care unit of a Dedicated COVID Hospital: A retrospective observational study." National Journal of Physiology, Pharmacy and Pharmacology 12 (2022), 472-476. doi:10.5455/njppp.2022.12.09345202126092021

MLA (The Modern Language Association) Style

Ismail, Teli Shaikh Emaran Shaikh, Chetan Suresh Bhangale, Harshal M Mahajan, and Vijay B Gaikwad. "Drug prescribing pattern and clinical outcome in intensive care unit of a Dedicated COVID Hospital: A retrospective observational study." National Journal of Physiology, Pharmacy and Pharmacology 12.4 (2022), 472-476. Print. doi:10.5455/njppp.2022.12.09345202126092021

APA (American Psychological Association) Style

Ismail, T. S. E. S., Bhangale, . C. S., Mahajan, . H. M. & Gaikwad, . V. B. (2022) Drug prescribing pattern and clinical outcome in intensive care unit of a Dedicated COVID Hospital: A retrospective observational study. National Journal of Physiology, Pharmacy and Pharmacology, 12 (4), 472-476. doi:10.5455/njppp.2022.12.09345202126092021

Author Login Reviewer Login About Publisher Editorial Policies Editorial Review Policy Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article


About National Journal of Physiology, Pharmacy and Pharmacology National Journal of Physiology, Pharmacy and Pharmacology is a monthly peer reviewed journal. The journal is having open access polic ... Read more. For best results, please use Internet Explorer or Google Chrome.	Contact Information Publisher publishernjppp@gmail.com Editorial query editornjppp1@gmail.com MOB - 8780040272